Neulasta® - Order Materials

Order

Materials

To order educational materials about Neulasta^®, please select the resources you would like to receive and complete the form below.

You must check at least one box to continue:

By My Side™ Chemotherapy Brochure (P43072-1)

Neulasta^® Patient Education Brochure (P49039)

Items in BOLD are required

First Name:

Last Name:

E-mail:

I am a:

Street Address:

City:

State:

Zip Code:

Country:

Phone:

ext.


	Neulasta^® (pegfilgrastim) is indicated to decrease the incidence of infection, as manifested by febrile neutropenia, in patients with nonmyeloid malignancies receiving myelosuppressive anticancer drugs associated with a clinically significant incidence of febrile neutropenia. Important Product Safety Information Neulasta^® Prescribing Information \| NEUPOGEN^® (Filgrastim) Prescribing Information \| Medical Information Connection™ \| Site Map \| Amgen.com 2008 Amgen. All rights reserved. This site for use in U.S. only.